Search Results - "COMANDUCCI, Maurizio"
-
1
Qualitative and quantitative assessment of meningococcal antigens to evaluate the potential strain coverage of protein-based vaccines
Published in Proceedings of the National Academy of Sciences - PNAS (09-11-2010)“…A uniquemulticomponent vaccine against serogroup B meningococci incorporates the novel genome-derived proteins fHbp, NHBA, and NadA that may vary in sequence…”
Get full text
Journal Article -
2
Predicted Strain Coverage of a New Meningococcal Multicomponent Vaccine (4CMenB) in Spain: Analysis of the Differences with Other European Countries
Published in PloS one (07-03-2016)“…A novel meningococcal multicomponent vaccine, 4CMenB (Bexsero®), has been approved in Europe, Canada, Australia and US. The potential impact of 4CMenB on…”
Get full text
Journal Article -
3
Neisseria meningitidis is structured in clades associated with restriction modification systems that modulate homologous recombination
Published in Proceedings of the National Academy of Sciences - PNAS (15-03-2011)“…Molecular data on a limited number of chromosomal loci have shown that the population of Neisseria meningitidis (Nm), a deadly human pathogen, is structured in…”
Get full text
Journal Article -
4
A Universal Vaccine for Serogroup B Meningococcus
Published in Proceedings of the National Academy of Sciences - PNAS (18-07-2006)“…Meningitis and sepsis caused by serogroup B meningococcus are two severe diseases that still cause significant mortality. To date there is no universal vaccine…”
Get full text
Journal Article -
5
An analysis of the sequence variability of meningococcal fHbp, NadA and NHBA over a 50-year period in the Netherlands
Published in PloS one (24-05-2013)“…Studies of meningococcal evolution and genetic population structure, including the long-term stability of non-random associations between variants of surface…”
Get full text
Journal Article -
6
Characterization of fHbp, nhba (gna2132), nadA, porA, and Sequence Type in Group B Meningococcal Case Isolates Collected in England and Wales during January 2008 and Potential Coverage of an Investigational Group B Meningococcal Vaccine
Published in Clinical and Vaccine Immunology (01-06-2010)“…Classifications Services CVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
Get full text
Journal Article -
7
Fine Antigenic Specificity and Cooperative Bactericidal Activity of Monoclonal Antibodies Directed at the Meningococcal Vaccine Candidate Factor H-Binding Protein
Published in Infection and Immunity (01-09-2008)“…No broadly protective vaccine is available for the prevention of group B meningococcal disease. One promising candidate is factor H-binding protein (fHbp),…”
Get full text
Journal Article -
8
Characterization of Diverse Subvariants of the Meningococcal Factor H (fH) Binding Protein for Their Ability To Bind fH, To Mediate Serum Resistance, and To Induce Bactericidal Antibodies
Published in Infection and Immunity (01-02-2011)“…Neisseria meningitidis is a commensal of the human nasopharynx but is also a major cause of septicemia and meningitis. The meningococcal factor H binding…”
Get full text
Journal Article -
9
Characterization of fHbp, nhba (gna2132), nadA, porA, Sequence Type (ST), and Genomic Presence of IS1301 in Group B Meningococcal ST269 Clonal Complex Isolates from England and Wales
Published in Journal of Clinical Microbiology (01-11-2009)“…Highly effective glycoconjugate vaccines exist against four of the five major pathogenic groups of meningococci: A, C, W-135, and Y. An equivalent vaccine…”
Get full text
Journal Article -
10
NadA, a novel vaccine candidate of Neisseria meningitidis
Published in The Journal of experimental medicine (03-06-2002)“…Neisseria meningitidis is a human pathogen, which, in spite of antibiotic therapy, is still a major cause of mortality due to sepsis and meningitis. Here we…”
Get full text
Journal Article -
11
NadA Diversity and Carriage in Neisseria meningitidis
Published in Infection and Immunity (01-07-2004)“…Classifications Services IAI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
Get full text
Journal Article -
12
Region Comprising Amino Acids 100 to 255 of Neisseria meningitidis Lipoprotein GNA 1870 Elicits Bactericidal Antibodies
Published in Infection and Immunity (01-02-2005)“…GNA 1870 is a novel surface-exposed lipoprotein, identified by genome analysis of Neisseria meningitidis strain MC58, which induces bactericidal antibodies…”
Get full text
Journal Article -
13
Mu-Like Prophage in Serogroup B Neisseria meningitidis Coding for Surface-Exposed Antigens
Published in Infection and Immunity (01-04-2001)“…Classifications Services IAI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
Get full text
Journal Article -
14
Neisseria meningitidis factor H-binding protein fHbp: a key virulence factor and vaccine antigen
Published in Expert review of vaccines (01-06-2015)“…Neisseria meningitidis is a leading cause of meningitis and sepsis worldwide. The first broad-spectrum multicomponent vaccine against serogroup B meningococcus…”
Get more information
Journal Article -
15
Could the multicomponent meningococcal serogroup B vaccine (4CMenB) control Neisseria meningitidis capsular group X outbreaks in Africa?
Published in Vaccine (04-02-2013)“…Highlights ► A new recombinant vaccine against meningococci group B is under registration. ► We examined coverage of group X isolates emerging in Africa (no…”
Get full text
Journal Article -
16
Distribution and genetic variability of three vaccine components in a panel of strains representative of the diversity of serogroup B meningococcus
Published in Vaccine (11-05-2009)“…Abstract With the aim of studying the molecular diversity of the antigens of a new recombinant vaccine against meningococcus serogroup B, the three genes…”
Get full text
Journal Article -
17
Genetic Meningococcal Antigen Typing System (gMATS): A genotyping tool that predicts 4CMenB strain coverage worldwide
Published in Vaccine (08-02-2019)“…The Meningococcal Antigen Typing System (MATS) was developed to identify meningococcus group B strains with a high likelihood of being covered by the 4CMenB…”
Get full text
Journal Article -
18
Multicomponent meningococcal serogroup B vaccination elicits cross-reactive immunity in infants against genetically diverse serogroup C, W and Y invasive disease isolates
Published in Vaccine (03-11-2020)“…•4CMenB antigens are present and conserved in non-MenB meningococcal strains.•The antigens vary across strains in their presence, sequence relatedness and…”
Get full text
Journal Article -
19
Predicted strain coverage of a meningococcal multicomponent vaccine (4CMenB) in Europe: a qualitative and quantitative assessment
Published in The Lancet infectious diseases (01-05-2013)“…Summary Background A novel multicomponent vaccine against meningococcal capsular group B (MenB) disease contains four major components: factor-H-binding…”
Get full text
Journal Article -
20
Rational design of a meningococcal antigen inducing broad protective immunity
Published in Science translational medicine (13-07-2011)“…The sequence variability of protective antigens is a major challenge to the development of vaccines. For Neisseria meningitidis, the bacterial pathogen that…”
Get more information
Journal Article